
Please try another search
Industrial goods manufacturer IDEX Corporation (NYSE:IEX) recently inked a definitive agreement to acquire German firm — thinXXS Microtechnology AG — for an undisclosed amount. Post acquisition, thinXXS will form an integral part of the Health and Science Technologies segment of IDEX and will strengthen its presence in the global life science and veterinary markets with world-class products and solutions.
Located in Zweibrücken, Germany, thinXXS is a premier manufacturer of disposable microfluidic components for the point of care, veterinary and life science markets. It also develops various customer-specific solutions for applications in immunology, clinical chemistry, DNA analytic or cell-based research.
The acquisition is a strategic fit for IDEX’s core optics and scientific fluidics product portfolio that serves life science customers. The deal is the second of its kind in this space and strengthens the market position of the company as an undisputed leader in microfluidic technology.
Acquisitions have been IDEX’s most favored mode for penetrating unexplored markets, which extend its geographic reach, fill technology gaps and strengthen its foothold in the existing markets while expanding product lines.
At the same time, IDEX is striving to expand its businesses in the emerging markets by focusing on organic growth. The company reported organic growth of 7% in the third quarter of 2017 owing to a diligent execution of operational plans. IDEX aims to increase its market exposure and improve sales mix by continually developing new products. With a flexible yet disciplined focus on cost and productivity and a holistic growth model, IDEX has outperformed the industry with an average year-to-date return of 46.9% compared with a gain of 27.1% for the latter.
Since the Robotaxi event on October 11th, Tesla (NASDAQ:TSLA) stock is up 38%, currently priced at $291.60 per share This is a return to the early November 2024 price level. But...
The Q4 2024 earnings season tapers off from here, with S&P 500® EPS growth surpassing 17%, the highest in 3 years Large cap outlier earnings dates this week include:...
Shares of Alibaba (NYSE:BABA) are on a tear to start off 2025. The consumer discretionary and tech stock is up by 52% this year as of the Feb. 25 close. The company’s cloud...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.